Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Apr;49(2):343-80.
doi: 10.1016/j.otc.2015.11.001.

Diagnosis and Management of Malignant Salivary Gland Tumors of the Parotid Gland

Affiliations
Review

Diagnosis and Management of Malignant Salivary Gland Tumors of the Parotid Gland

Aaron G Lewis et al. Otolaryngol Clin North Am. 2016 Apr.

Abstract

Malignant parotid tumors are heterogeneous and diverse. Accurate diagnosis requires a pathologist familiar with the various histologic subtypes, immunohistochemistry stains, and common translocations. Clinical course varies according to tumor subtype, ranging from indolent, slow-growing adenoid cystic carcinoma to rapidly progressive, possibly fatal, salivary ductal carcinoma. Histologic grade is important in prognosis and therapy. Surgery remains the mainstay of treatment when negative margins can be achieved. Radiation improves locoregional control of tumors with high-risk features. Chemotherapy for parotid tumors can be disappointing. Studies of new targeted therapies have not offered significant benefits.

Keywords: Chemotherapy for parotid tumors; Genetic translocations of parotid tumors; Malignant salivary cancers; Molecular diagnostics; Molecular targeted therapies; Parotid cancer; Radiation therapy for parotid cancers; Surgery for parotid salivary cancer.

PubMed Disclaimer

LinkOut - more resources